HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Statins, the widely used cholesterol drugs with a global market over $25 billion, are gaining wide attention as a potential new way of treating Alzheimer’s disease (AD) according to recent reports. The Wall Street Journal noted the promise of statins for Alzheimer’s disease and highlighted the pressing need for new and effective treatments for this major disease (October 17, 2006 Several Drugs Show Promise For Alzheimer’s). A series of recent scientific studies have explored the link between Alzheimer’s disease, cognitive function and high cholesterol levels and other cardiovascular risk factors, and the possible role that statins may have in treating or preventing Alzheimer’s disease.
